These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 33143687

  • 1. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y, Shiroiwa T, Taira N, Kawahara T, Konomura K, Noto S, Fukuda T, Shimozuma K.
    Health Qual Life Outcomes; 2020 Nov 03; 18(1):354. PubMed ID: 33143687
    [Abstract] [Full Text] [Related]

  • 2. Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas.
    Xu RH, Wong ELY, Jin J, Dou Y, Dong D.
    Eur J Health Econ; 2020 Dec 03; 21(9):1363-1373. PubMed ID: 32960388
    [Abstract] [Full Text] [Related]

  • 3. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
    Meunier A, Soare A, Chevrou-Severac H, Myren KJ, Murata T, Longworth L.
    Appl Health Econ Health Policy; 2022 Jan 03; 20(1):119-131. PubMed ID: 34554442
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients.
    Perwitasari DA, Purba FD, Candradewi SF, Marwin M, Permata A, Ulfa Faza MB, Septiantoro BP, Kaptein AA.
    Asian Pac J Cancer Prev; 2023 Apr 01; 24(4):1125-1130. PubMed ID: 37116132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
    Liu T, Li S, Wang M, Sun Q, Chen G.
    Patient; 2020 Oct 01; 13(5):537-555. PubMed ID: 32382953
    [Abstract] [Full Text] [Related]

  • 9. Mapping the EORTC QLQ-C30 and QLQ H&N35 to the EQ-5D-5L and SF-6D for papillary thyroid carcinoma.
    Huang D, Zeng D, Tang Y, Jiang L, Yang Q.
    Qual Life Res; 2024 Feb 01; 33(2):491-505. PubMed ID: 37938402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN, Olsen JA.
    Qual Life Res; 2018 Nov 01; 27(11):2823-2839. PubMed ID: 30173314
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma.
    Arnold DT, Rowen D, Versteegh MM, Morley A, Hooper CE, Maskell NA.
    Health Qual Life Outcomes; 2015 Jan 23; 13():6. PubMed ID: 25613110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.